Teradyne in FormFactor Investment and Strategic Collaboration

October 14, 2026

Cleary Gottlieb is representing Teradyne Inc. (Teradyne) in its investment in common stock of FormFactor Inc. (FormFactor) and related strategic collaboration.

The stock purchase agreement and collaboration agreement governing the transactions were signed on October 6, 2026, and the stock purchase is expected to close before the end of the year, subject to customary conditions.

Teradyne and FormFactor will collaborate on joint solutions that combine Teradyne’s test platforms with FormFactor’s probe, contactor, and interface technologies to help semiconductor customers accelerate validation, reduce integration risk, and bring advanced devices to production faster.

Teradyne designs, develops, and manufactures automated test equipment and advanced robotics systems. Its semiconductor and electronics test solutions span the full AI device supply chain, from wafer to data center, enabling customers to meet the quality and reliability standards the AI era demands. Its advanced robotics business deploys intelligent automation across manufacturing, logistics, and data center operations for customers worldwide.

The Cleary corporate and securities team includes partner J.T. Ho and counsel David Parish, with additional support from partner Chris R. Moore. Partner Daniel Ilan and associate Natalie Curry are advising on intellectual property matters. Partners Jeremy Calsyn and Steven Kaiser and associates Eun Joo Hwang and Jonathan Glustein are advising on antitrust matters.